Yale Cancer Center

https://www.yalecancercenter.org/

 

GU
01:46

ASCO GU 2023 Conference Coverage

ASCO GU 2023 Randomized Double-Blind Phase 3 KEYNOTE-921 Study: Pembro + Docetaxel for Patients With mCRPC

FEATURING Daniel Petrylak
  • 65 views
  • February 28, 2023
  • 1
10:55

Yale Cancer Center

Systemic Therapies for Clear Cell RCC: Where Are We Now?

FEATURING David Braun
  • 311 views
  • December 23, 2022
  • 1
04:55

Yale Cancer Center

Post-Hoc Analyses of Phase 3 ARCHES Trial: OS in Patients With mHSPC Who Received Prior ADT and Reached Low PSA Levels Treated Further With Enzalutamide

FEATURING Daniel Petrylak
  • 319 views
  • December 16, 2022
18:43

Yale Cancer Center

Smilow Shares with Primary Care: Prostate Cancer Screening Case 47 y/o Male With Family History of Prostate Cancer

FEATURING Erin Culbert
  • 32 views
  • September 19, 2022
07:51

Yale Cancer Center

Prostate Cancer Case Discussion: 57 y/o Asymptomatic Male With PSA of 5.6

FEATURING Gerald Portman
  • 57 views
  • September 19, 2022
10:09

Yale Cancer Center

Yale Cancer Center Radiation Therapy Updates for Prostate Cancer

FEATURING Bruce McGibbon
  • 198 views
  • September 19, 2022
  • 1
05:46

Yale Cancer Center

Prostate Cancer Case Discussion: 82 y/o Male With Gleason 9 Adenocarcinoma With Multiple Bone Mets

FEATURING Daniel Petrylak
  • 262 views
  • September 19, 2022
  • 1
12:24

Yale Cancer Center

2020 Highlights on Anti-Androgens in High-Risk PC: Does ADT+Abiraterone Combo Improve OS? How Does the Addition of Olaparib After Docetaxel Affect PFS?

FEATURING Daniel Petrylak
  • 13 views
  • September 27, 2020
13:36

Yale Cancer Center

What Are the Clinical Outcomes of Patients Treated With Local Therapies With Oligometastatic Renal Cell Carcinoma?

FEATURING Zhan Wu
  • 4 views
  • June 26, 2020
16:59

Yale Cancer Center

Prostatectomy vs. Radiation in Localized Prostate Cancer: Which Treatment Regimen Provides More Benefit?

FEATURING Bryan Kaps
  • 21 views
  • June 26, 2020
05:33

Yale Cancer Center

2020 ASCO Update on CPIs in mUC: What Are the FDA Approved CPIs? Should the Checkpoint Therapy Be Moved Up Earlier? Is There a Benefit of CPIs in Adjuvant Setting?

FEATURING Daniel Petrylak
  • 334 views
  • June 12, 2020
  • 2